@mrdannysullivan Profile picture

Danny Sullivan

@mrdannysullivan

Contributing Editor at @LongevityTech. Writer, marketer, PR'er, traveller, reader, runner, technolover and lots of other ers...

Similar User
Stephanie Dainow photo

@sdainow

Alaattin Kaya photo

@akaya_lab

Translating Aging photo

@BioAgePodcast

Sebastian A. Brunemeier 🏴 🌎 💊 🧬 photo

@sebastian_gero

Juvify Health photo

@Juvifyhealth

Longevity photo

@Longevityyyyy

Aleksey Belikov photo

@AlekseyVBelikov

Carol photo

@_Carol_Mag

Cambridge Society of Ageing and Longevity Research photo

@culongevity

Alexandra S. Bause photo

@AlexandraBause

Edward Anderton photo

@EdwardAnderton7

Andrei Tarkhov photo

@Andrei_Tarkhov

Daniel Ives photo

@dives86

Brad English photo

@brad_w_e

Aastha Jain Simes photo

@aasthajs

Danny Sullivan Reposted

‘We’re targeting the biggest causes of age-related morbidity and mortality’ Rubedo’s new CEO discusses the potential for senolytics in aging and healthspan as company gears up for clinical trials. #longevity #biotech #senolytics #senescence longevity.technology/news/were-targ…

Tweet Image 1

Danny Sullivan Reposted

Graphene implants decode the complexities of the human brain Inbrain CEO explains how new advances in BCI technology have the potential to diagnose and treat multiple brain conditions in real-time. #longevity #neurotech #graphene #BCI #brain longevity.technology/news/graphene-…

Tweet Image 1

Danny Sullivan Reposted

Alzheimer’s researchers land $6.2m NIA grant to build portable brain scanner #longevity #Alzheimers #diagnostics #brain #radiology longevity.technology/news/alzheimer…

Tweet Image 1

Danny Sullivan Reposted

Some encouraging results in human Alzheimer’s patients from a cell therapy delivered directly into the brain. We also plan on direct delivery of our Yamanaka factor partial reprogramming therapy at YouthBio (some people ask if the FDA’d be ok with it). longevity.technology/news/first-dat…


Danny Sullivan Reposted

First data emerges from ‘direct-to-brain’ Alzheimer’s stem cell therapy trial @RegenBiomed presents early data showing stem cell treatment reduced levels of p-Tau and amyloid-beta in #Alzheimers patients. #longevity #stemcells #biotech longevity.technology/news/first-dat…

Tweet Image 1

Danny Sullivan Reposted

Artificial thymus organoid demonstrates immune-boosting potential FibroBiologics CSO explains how a fibroblast-enabled artificial thymus may hold the key to restoring and maintaining immune system function as we age. #longevity #immune #aging #thymus longevity.technology/news/artificia…

Tweet Image 1

Danny Sullivan Reposted

AbbVie snaps up Phase 1 #Alzheimers #biotech for $1.4bn Aliada Therapeutics specializes in therapeutics with the ability to penetrate the blood-brain barrier and achieve targeted delivery to the brain. @abbvie #longevity #investment #acquisition longevity.technology/news/abbvie-sn…

Tweet Image 1

Danny Sullivan Reposted

Rejuvenate Biomed to commence Phase 2 sarcopenia trial Clinical study to explore potential of metformin and galantamine combination to address sarcopenia in patients with COPD. #longevity #biotech #sarcopenia #COPD longevity.technology/news/rejuvenat…

Tweet Image 1

Danny Sullivan Reposted

Gameto lands ARPA-H funding to combat menopause with cell therapy Company to receive $10m for menopause-targeting therapies based on cell engineering platform developed in collaboration with George Church. #longevity #funding #biotech #menopause longevity.technology/news/gameto-la…

Tweet Image 1

Danny Sullivan Reposted

Cristiano Ronaldo invests in personalized supplements firm with longevity in its sights CR7 becomes ‘significant shareholder’ in Bioniq, a provider of personalized supplements based on blood biomarker data and AI. #longevity #investment #supplements #CR7 longevity.technology/news/cristiano…

Tweet Image 1

Danny Sullivan Reposted

Terray lands $120m to advance AI discovered drugs to the clinic Leveraging world’s largest chemistry dataset, AI drug discovery company has age-related diseases in its sights via Calico collaboration. #longevity #investment #AI #biotech longevity.technology/news/terray-la…

Tweet Image 1

Danny Sullivan Reposted

Can boosting the proteasome provide the answer to neurodegeneration? Booster Therapeutics founder says treating complex diseases requires targeting and degrading multiple toxic proteins at the same time. #longevity #biotech #neurodegeneration #aging longevity.technology/news/can-boost…

Tweet Image 1

Danny Sullivan Reposted

Tolerance Bio launches to boost human healthspan via the thymus Company lands $17.2m to preserve, regenerate and manipulate the thymus to combat immune diseases and extend healthy lifespan. #longevity #investment #healthspan #immune #thymus longevity.technology/news/tolerance…

Tweet Image 1

Danny Sullivan Reposted

Shift Bio lands $16m to identify safe #rejuvenation genes... @ShiftBioscience’s platform identifies gene-factors likely to rejuvenate cells without triggering the risks associated with using #Yamanakafactors. #longevity #ShiftBioscience @dives86 longevity.technology/news/shift-bio…


Danny Sullivan Reposted

Arda targets chronic diseases and aging with ‘targeted cell depletion’ therapies On a mission to extend healthy lifespan, startup lands $43m to target and eliminate the cells that drive disease and aging. @a16z #longevity #aging #biotech #healthspan longevity.technology/news/arda-targ…

Tweet Image 1

Danny Sullivan Reposted

MitoRx demonstrates mitochondrial therapy holds potential in metabolic disease... Study shows #mitochondria-targeted donor therapy reduces #weightgain and protects against #muscleloss in mice @MitoRxTheraLtd @BiotechJon #longevity #obesity #biotech #GLP1 longevity.technology/news/mitorx-de…


Danny Sullivan Reposted

Integrated Bio lands $17m to accelerate #longevity drug development Combining synthetic biology and AI, company seeks to modulate key cellular processes to combat age-related diseases and promote healthy aging. #investment #AI #drugdiscovery #biotech longevity.technology/news/integrate…

Tweet Image 1

Danny Sullivan Reposted

Kailera emerges with $400m to advance next-generation weight loss drugs Company is developing dual agonist and tri-agonist drugs that target GLP-1 alongside other metabolic hormones like GIP and glucagon. #longevity #investment #weightloss #GLP1 longevity.technology/news/kailera-e…

Tweet Image 1

Danny Sullivan Reposted

Can a ‘longevity state’ accelerate therapies against aging? The network state concept could give longevity biotech the impetus to enable ‘warp speed’ development of age-reversing therapeutics. #longevity #networkstate #decentralization longevity.technology/news/can-a-lon…

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.